Other languages Cardiff Oncology, Inc.

Equities

CRDF

US14147L1089

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-24 pm EDT			5-day change	1st Jan Change
3.44 ^USD	+4.24%		-5.23%	+132.43%

May. 02	Transcript : Cardiff Oncology, Inc., Q1 2024 Earnings Call, May 02, 2024
May. 02	Cardiff Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cardiff Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 02
Cardiff Oncology Presents Novel Preclinical Data At Aacr Annual Meeting 2024 That Supports Ongoing First-Line Ras-Mutated Mcrc Clinical Study	Apr. 08
Sector Update: Health Care Stocks Rising Late Afternoon	Mar. 01
Sector Update: Health Care	Mar. 01
Cardiff Oncology Shares Jump, Discontinued Cancer Treatment Trial Shows Efficacy	Mar. 01
Cardiff Oncology, Inc. Announces First Patient Dosed in Randomized First-Line RAS-Mutated Metastatic Colorectal Cancer Trial (CRDF-004)	Feb. 29
Cardiff Oncology, Inc. Provides Clinical Update on Phase 2 Randomized Second-Line ONSEMBLE Trial in Patients with RAS-Mutated mCRC	Feb. 29
Cardiff Oncology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29
Cardiff Oncology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 02
LATE BRIEFING - Unternehmen und Märkte	23-09-27
MÄRKTE USA/Börsen erneut im Minus - Verunsichung dauert an	23-09-27
MÄRKTE USA/Börse leicht erholt von Vortagesverlusten	23-09-27
MÄRKTE USA/Börse mit kleiner Gegenbewegung auf Vortagesverluste erwartet	23-09-27
Top Premarket Gainers	23-09-27
MIDDAY BRIEFING - Unternehmen und Märkte	23-09-27
MARKT USA/Etwas fester - Kleine Gegenbewegung auf Vortagesverluste	23-09-27
MORNING BRIEFING - USA/Asien	23-09-27
Cardiff Oncology Reports 'Positive' Results From Onvansertib Monotherapy Trial for Pancreatic, Small Cell Lung Cancers	23-09-26
Cardiff Oncology, Inc. Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, Including Single-Agent Activity from Onvansertib Monotherapy	23-09-26
Cardiff Oncology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Cardiff Oncology, Inc.

Equities

CRDF

US14147L1089

Other languages

Filters